Appeals Procedure for Applicants
National Heart, Lung, and Blood Institute
National Institutes of Health
The intent of the appeals process is to provide an avenue for resolving any
procedural issues surrounding the initial peer review of an application. The
appeals process is used when the issue cannot be resolved administratively.
Additional information on the appeals of initial scientific review can be found
in the NIH Guide Notice, Appeals of NIH Peer Review, NOT-OD-11-064: April 15, 2011.
There are four types of procedural flaws that can form the basis of an appeal:
- confict of interest
- lack of appropriate scientific expertise
- factual errors.
Differences in scientific opinion and concerns or complaints about those
policies regulating the conduct of initial peer review are not grounds for an
An applicant who is concerned about any procedural aspect of the completed
initial peer review of an application should first consider the comments in the
summary statement and then contact the appropriate NHLBI Program Official (PO).
The PO may answer questions about the summary statement and review outcome as
well as provide guidance to the applicant.
Letters addressing the peer review of grant applications are carefully evaluated
by senior Institute staff to determine whether the issues raised constitute a
formal appeal, as defined in the NIH Guide Notice, referenced above. Letters of
appeal must document concurrence from the Authorized Organization Representative
of the applicant institution. Only those letters deemed formal appeals are taken
to the National Heart, Lung, and Blood Advisory Council (NHLBAC) for discussion.
NIH-wide policy prohibits the simultaneous submission and review of a resubmission (amended)
application if an appeal of the original application is pending. An application
is in a pending status until the NHLBAC has made a decision on the appeal. The
NIH-wide policy on resubmissions is based on the long-standing policy not to accept an application that is essentially the same as one currently
pending initial or secondary (i.e., Council) peer review. Therefore, if an
appeal of the original application is pending Council review, then the applicant
organization must withdraw the appeal of the original application in order to
submit a resubmission (amended) application.
Appeal letters concerning the initial peer review outcome of applications submitted in response to Requests for Applications (RFAs) will not be accepted. For more information, please refer to section 2.4.2 (Appeals of Initial Scientific Review) of the NIH Grants Policy Statement (dated 10/1/2011).
- The deadline for receipt of valid appeal letters is 12 working days prior to the
closed session of the Council meeting, when appeals are considered.
- In order for NIH staff and Council members to give careful and full
consideration to an appeal, every effort should be made to ensure that valid
appeals letters arrive 12 or more working days before the closed session of the
- The NHLBI recognizes that there may be extenuating circumstances that prevent a
letter from arriving by the deadline, and such letters will be brought to the
subsequent Council meeting. That is, valid appeal letters received from 11
working days prior to and 30 calendar days after the closed session Council
meeting will be deliberated at the next Council meeting.
- Meeting dates for the Council can be found at: http://www.nhlbi.nih.gov/about/committees/nhlbac/index.htm#meeting
The applicant will be notified about Councilís decision within 30 working days
after Councilís deliberation of the appeal.
Last Updated: April 2014